Skip to main content
. 2015 Jul-Sep;11(3):166–171. doi: 10.14797/mdcj-11-3-166

Figure 2.

Figure 2.

Endogenous factors that contribute to reduced nitric oxide (NO) bioavailability. Reduced NO directly contributes to vascular dysfunction and development of cardiovascular disease. iNOS: inducible NO synthase (NOS); eNOS: endothelial NOS; CAT: cationic amino acid transporter; ADMA: asymmetric dimethylarginine; OxLDL: oxidized low density lipoprotein.